Abstract
Building on our initial work, we have identified additional novel inhibitors of sphingosine kinase-1 (SK1). These new analogs address the shortcomings found in our previously reported compounds. Inhibitors 51 and 54 demonstrated oral bioavailability in a rat PK study.
Published by Elsevier Ltd.
MeSH terms
-
Animals
-
Benzaldehydes / chemical synthesis
-
Benzaldehydes / chemistry*
-
Benzaldehydes / pharmacokinetics
-
Drug Evaluation, Preclinical
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry*
-
Enzyme Inhibitors / pharmacokinetics
-
Humans
-
Lithium / chemistry*
-
Microsomes, Liver / metabolism
-
Phosphotransferases (Alcohol Group Acceptor) / antagonists & inhibitors*
-
Phosphotransferases (Alcohol Group Acceptor) / metabolism
-
Rats
Substances
-
Benzaldehydes
-
Enzyme Inhibitors
-
Lithium
-
4-cyanobenzaldehyde
-
Phosphotransferases (Alcohol Group Acceptor)
-
sphingosine kinase